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Abstract
Background: Oftentimes, cancer advocates in Africa look at the developed nations in North America and Europe
for guidance on cancer advocacy. However, lessons learnt from developed nations do not necessarily apply to the
situational context of Africa. Without a doubt, successful cancer advocates in Africa can best serve as learning
sources and role models for advocacy in Africa. This paper describes the results of an environmental scan of
advocacy organizations in Africa.
Methods: A cross-sectional study design was employed for this project. Using a structured survey data collection
form, participants submitted their responses either by online submission (Google docs) or by electronic mail to
admin@aortic-africa.org.
Results: A total of 39 African advocates representing 17 countries participated in the project. The majority of
participants have been advocates for more than five years; and mostly advocate for both males and females and
individuals between the ages of 30 and 39. The most common cancers focused on by the advocacy organizations
include breast, prostate, liver, cervix, stomach, bladder, pediatric, colorectal and neck. The information provided by
participants offer clear guidelines on establishing and maintaining an advocacy program in Africa despite the
various challenges faced by these organizations.
Conclusion: Whilst this paper only highlights a subset of advocacy initiatives on the Continent, there is an
opportunity for a more inclusive dialogue for advocates to share ideas with each other, connect with other
advocates, learn about other innovative advocacy programs, and join the global war against cancer. To this end,
the biennial International Workshop on Cancer Advocacy for African Countries (CAAC) during the next AORTIC
International Cancer conference, offers an opportunity to further Africa’s cancer advocacy initiatives.
Introduction
“In Africa, literally every day, hundreds, possibly thou-
sands of people die needlessly in pain from cancer for
want of pain relief that could cost literally pennies rather
than pounds. The basic infrastructure and resources to
cope with the new health epidemic is basically not there
and we have to do something about it. We know that
there is a steam train that is coming down the track and
we have a choice - we can wither, build some new track or
we can wait for the train to hit us.”
Former British health minister Alan Milburn’s state-
ments while chairing the conference on the geography
of cancer in Africa (2007).
The need for cancer advocacy in Africa is indisputa-
ble. Advocacy is widely seen as the new track needed to
stop the stream train of cancer. Defined as the “effort to
influence people, primarily decision-makers, to create
change, which in the context of cancer control results in
comprehensive policies and effective program implemen-
tation, through various forms of persuasive communica-
tion”,[1] cancer advocacy is in its infancy in Africa. This
is rather unfortunate given that successful national can-
cer control planning and implementation cannot take
place without advocacy. Active advocacy will be pivotal
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to turn the tide on the cancer crisis and make issues
related to the disease a high priority in Africa.
Although cancer advocacy is not widespread in Africa,
there are some individuals who are deeply committed to
fighting the disease in Africa, even with limited
resources and support. These individuals work tirelessly
to conquer cancer within their communities, countries
and the continent by mobilizing the limited resources
within Africa for cancer control, partnering with key
stakeholders to increase awareness about the disease,
fundraising to support their activities, and implementing
programs sensitive to the needs of their communities.
Cancer advocates in Africa are the everyday heroes of
Africa.
In general, new cancer advocates in Africa look at the
developed nations in North America and Europe for
guidance on cancer advocacy. However, lessons learnt
from developed nations often are not applicable to the
circumstances in developing countries due to the signifi-
cant differences in the situational context. Given that
some (although few) cancer advocates have successfully
implemented advocacy programs in Africa, sometimes
in spite of and under adverse conditions, these advo-
cates can best serve as learning sources and role models
for advocacy in Africa. The African Organisation for
Research and Training in Cancer (AORTIC) thus con-
ducted an environmental scan of the African continent
to showcase these outstanding cancer advocacy practices
by various organizations in Africa.
African Organisation for Research and Training in
Cancer (AORTIC)
AORTIC is Africa’s pre-eminent non-profit organization
working for cancer control. AORTIC achieves its mission
not only by facilitating research and training, but also by
providing relevant and accurate information on the pre-
vention, early diagnosis, treatment, and palliation of can-
cer. A key interest of the organization is advocacy, as it is
dedicated to increasing public awareness of cancer and
reducing the stigma associated with it. With membership
from countries throughout Africa and the international
cancer community, the main objectives of AORTIC are
to further research related to cancers prevalent in Africa,
enable and support training initiatives in oncology for
health care workers, create cancer prevention and control
programs, and to raise public awareness of cancer on the
continent. AORTIC strives to unite the African continent
in achieving its goal of a cancer-free Africa and seeks to
make a positive impact throughout the region through
collaboration with health ministries and global cancer
organizations.
One way in which AORTIC achieves its objectives is
by promoting advocacy in Africa. Thereby, in line with
the mission of AORTIC, the primary objectives of this
study were to: (i) describe the types of cancer advocacy
being practiced in Africa and (ii) identify essential
recommendations for new cancer advocates and those
considering being involved in cancer advocacy.
Methods
We employed a cross-sectional study design using a
structured survey data collection form. The data collec-
tion form (see Additional file 1) was developed by inves-
tigators and comprised both open- and close-ended
questions. The form started with a request for back-
ground information on the cancer advocacy organization
and the advocate, including how long the respondent
has been an advocate, the average age of the clients, the
primary gender targeted by the organization, and the
types of cancer targeted. Next, participants were asked
to describe their cancer advocacy activities, including
the types of advocacy practiced by the organization -
political, support, fundraising, community outreach,
education, and/or research. They also listed the top
three recommendations they would give to someone try-
ing to establish an advocacy program.
The face validity of the data collection form was estab-
lished by two African-American cancer advocates in the
United States. We did not ask cancer advocates in Africa
to pretest the survey because we did not want to lose
potential participants for the project. The two advocates
who pre-tested the data collection form were asked to
read and complete the survey. Subsequently, they were
contacted and asked to provide feedback on the form,
including comprehension, ease of administration, and the
length of completion of the survey. Following the pretest,
no changes were made as the two advocates expressed
that the data collection form was appropriate for the
environmental scan project. It is worth noting that
employing advocates in the United States for the face
validation of the data collection form is a potential limita-
tion given the differences between North American and
African countries. However, participants of this project
did not indicate any difficulty in completing the data col-
lection form. While we are cognizant of the fact that
Africa is multi-lingual, the data collection form was in
English only. In subsequent studies, consideration will be
given to administer the survey in English and French.
A convenient but targeted sampling method was
employed to recruit participants as follows: (i) electronic
mails sent to members of AORTIC; (ii) electronic mails
sent to 51 members of the African Cancer Advocates
Consortium; and (iii) survey information provided on
the AORTIC website. Participants submitted their
responses either by online submission (Google docs) or
by electronic mail to admin@aortic-africa.org. A data-
base of all responses was compiled in an excel spread-
sheet and descriptive analysis was used to summarize
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the characteristics of the advocacy organizations and the
types of cancer advocacy in Africa. From the open-
ended responses, we summarized the essential recom-
mendations for cancer advocacy in Africa.
Results
The first wave of data collection ended on Friday, August
17, 2012. There were a total of 42 responses with three
responses from advocates outside Africa. The three non-
African responses were excluded from the data analyses.
The 39 African advocates represented 17 countries, with
the majority of the participants from Nigeria (28.21%).
The 17 countries represented in this survey are: Nigeria
(11 participants); Uganda (3 participants); Kenya (3 partici-
pants); Egypt (3 participants); South Africa (3 participants);
Guinea (2 participants); Tanzania (2 participants); Ghana
(2 participants); Sierra Leone (2 participants); Ethiopia (1
participant); Sudan (1 participant); Algeria (1 participant);
Mali (1 participant); Namibia (1 participant); Malawi (1
participant); Zambia (1 participant); and Zimbabwe (1 par-
ticipant). Table 1 provides a summary of the characteris-
tics of the participants. The majority of participants have
been advocates for more than five years, and both males
and females between the ages of 30 and 39 are targeted by
their organizations. It is interesting to note that most of
the advocacy organizations focus on Education Advocacy
while only a few focus on Political Advocacy. The partici-
pants target a range of cancer types. However, the most
common cancers are breast, prostate, liver, cervix, sto-
mach, bladder, pediatric, colorectal and neck. About 25%
of the participants indicated that their organizations focus
on all types of cancer, while about 10% indicated focus on
tobacco-related cancers.
Identification of community needs
One of the primary factors critical to successful advo-
cacy is to meet the needs of the community. Participants
were asked how they identify community needs for their
advocacy programs. A participant from Algeria reported
the identification of community needs through the sta-
tistical trend of cancer incidence, survival, and stage of
cancer. In Uganda, an advocacy organization employs
needs assessment surveys and insights from community
outreach events to identify the needs of the community.
It was encouraging to see that almost half of the partici-
pants reported conducting needs assessment for their
targeted communities. Other methods employed by par-
ticipants to identify community needs are:
• Hospital records.
• Ministry of Health records.
Table 1 Characteristics of Participants (N=39)
Question Responses Frequency Percentage
How long have you been an advocate? Within past year (anytime less than 12
months ago)
4 10.26%
Within past 2 years (1 year but less than 2
years ago)
1 2.56%
Within past 5 years (2 years but less than 5
years ago)
9 23.08%
5 or more years ago 25 64.10%
What is the age of the population you serve? (Choose all that applies) Between 30 and 39 years 27 69.23%
Between 40 and 49 years 25 64.10%
Between 50 and 59 years 19 48.72%
Between 60 and 69 years 13 33.33%
Between 70 and 79 years 8 20.51%
80 years or above 5 12.82%
What is the primary gender that you target? Male only 0 0%
Female only 4 10.26%
Both male and female 35 89.74%
What types of advocacy does your program or organization focus on?
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• Scientific journal publications.
• Technical reports.
• Clinician observations.
• Research data from local institutions.
• Patient feedback from health events and by direct
contact with the organization.
• Interactions during community outreach.
• Support group meetings.
• Feedback from Community Health Workers.
Mission and key goals of advocacy programs
The advocacy mission and goals of participants’ organi-
zations ranged from broad initiatives to well-focused
agendas, reflecting the needs of the target population.
For example, the goals of an advocacy organization in
Tanzania reflect a mission to address tobacco-related
cancers and include:
• To facilitate the co-ordination of tobacco control
activities in Tanzania.
• To undertake tobacco control activities and cam-
paigns in Tanzania.
• To persuade the Tanzanian government to ratify and
fully implement the WHO Framework Convention on
Tobacco Control (WHO FCTC) Treaty.
• To improve implementation of the Tobacco Products
(Regulations) Act 2003 and such other laws that seeks to
control and stop the use of tobacco in Tanzania.
• To raise public awareness on the hazards of tobacco
use.
• To document and publicize information on tobacco
control in Tanzania.
• To promote research on alternative crops in tobacco
growing areas and, assist in securing markets for such
crops.
• To maintain close working relationships with gov-
ernment institutions, parliamentarians, the private sector
and all tobacco control stakeholders, with the aim of
mounting effective advocacy campaigns against tobacco
use in Tanzania.
The outcomes provided by this organization were: (i) a
strong and well organized members’ forum and network;
(ii) a society (particularly adults) aware of the effects of
tobacco use; (iii) a supportive society; and (iv) farmers
adopting alternative crops to tobacco (more than 70% in
southern Tanzania).
On the other hand an advocacy organization in Ethio-
pia focused on addressing cancer issues through public
health initiatives with the following goals:
1. Encourage policy dialogue among decision makers
for the formulation of legislations and implementation
of different public health issues
2. Actively work on the ratification and implementa-
tion of the WHO-Framework Convention on Tobacco
Control (FCTC).
3. Actively contribute towards the development of
directives to control tobacco products in Ethiopia by the
Food Medicine and Health Care Administration and
control Authority.
4. Undertake research gap assessment and prioritize
research topics.
5. Conduct research and public health evaluations
based on priority health issues.
6. Identify areas for review and promotion of policy
development.
Instead of targeting a specific cancer, an advocacy
organization in Nigeria focuses on political advocacy
and aims to: (i) Sensitize all levels of government on the
importance of establishing excellent cancer services and
networks; and (ii) Partner with governments, profes-
sionals and other non-governmental organizations
(NGOs) in health education related to cancer.
The expected outcomes identified by this Nigerian
organization are a society well informed about cancer,
government provision of good preventive and curative
cancer services, and networks supported by professional
associations, NGOs and other society groups.
In Egypt, an advocacy organization focused on women
empowerment with the goals of:
1. Eliminating cultural taboos of breast cancer and
breast health.
2. Breaking the wall of fear and silence between doc-
tors and the community.
3. Empowering women with the knowledge to take
action and help them make informed decisions about
treatment.
4. Developing media campaigns to encourage men to
get their women screened and to support them if they
are diagnosed with breast cancer.
In South Africa, one of the leading cancer advocacy
organizations was formed to address health equity for
cancer patients in the public sector, with specific goals
to:
1. Improve access to treatment for all cancer patients.
2. Ensure psycho-social support becomes part of
patient-centered care in oncology.
3. Promote early detection and cancer awareness.
4. Promote the right to a second opinion in oncology
for patients.
5. Ensure equity of cancer treatment.
6. Advocate for re-employment of patients.
7. Address stigma issues about cancer.
8. Advocate for a population-based cancer registry and
National Cancer Plan.
A Ugandan advocacy organization innovatively
assesses the outcomes of the program aims to track
their progress. The aims of the advocacy program are
to: (i) Advocate for the development and implementa-
tion of policies favoring control and management of
Odedina et al. Infectious Agents and Cancer 2013, 8(Suppl 1):S6
http://www.infectagentscancer.com/content/8/S1/S6
Page 4 of 6
cancer; (ii) Establish the prevalence of breast and cervi-
cal cancer in Uganda; (iii) Lobby government and other
stakeholders to increase financial and other resources by
50%; and (iv) Intensify breast and cervical cancer aware-
ness campaigns on early detection, diagnosis treatment
and provide support services.
At the time of this survey, the outcomes documented for
the Ugandan advocacy organization include: (i) increase in
the number of women taking action for early detection;
(ii) involvement of the government in cancer prevention
in the country; (iii) membership affiliation with the Union
for International Cancer Control (UICC) and International
Alliance for Patient Organisation (IAPO); (iv) formation of
two umbrella organizations, the Uganda Cancer Society
and the Uganda Non- Communicable Diseases Alliance;
and (v) improvement in cancer services in the country.
Recommendations for establishing and sustaining an
advocacy program
Finally, participants were asked to list the top recom-
mendations for establishing an advocacy program in
Africa. Some of the recommendations provided by parti-
cipants included:
• Conduct situational analysis to define the commu-
nity and conduct community needs assessment.
• Develop a strategic plan that includes, vision, mis-
sion, type of advocacy that will be implemented, feasible
and achievable goals, and strategies for implementing
goals.
• Set an action plan of evaluation and impact assess-
ment that will guarantee the sustainability of the advo-
cacy plan.
• Select the advocacy issue of concern to the commu-
nity and design an appropriate strategy to effectively
address the concern.
• Invest in a network of dedicated and committed
volunteers as part of the workforce.
• Identify and establish good relationship with all key
stakeholders, including the policy makers, other NGOs,
political leaders and health authorities.
• Work closely with the media in promoting programs.
• Get close to the people the organization wants to
advocate for, understand what they are going through
and let them work with the organization in helping to
lead the way.
• Partner with experienced professionals and build a
network of good will.
• Employ scientific data to develop and support pro-
gram activities.
• Knowledge is power, so it is essential to continu-
ously learn about cancer and advocacy issues that will
affect the program.
• Maintain a positive attitude towards the community
and the issue.
• Ensure that everyone representing the organization
is experienced and capable of dealing with the advocacy
issues.
• Be aware of advocacy resources and tools by organi-
zations such as the World Health Organization (WHO)
and AORTIC.
Conclusion
This paper is the first effort of an environmental scan of
cancer advocacy organizations to understand the current
status of cancer advocacy in Africa. Although cancer
advocacy in Africa may not be at the same level as seen
in Europe and North America, there are dedicated Afri-
can advocates who passionately employ innovative ways
to address cancer in Africa. Two advocacy areas that
need attention are Political Advocacy and Fundraising
Advocacy. Less than 20% of the organizations who parti-
cipated in this environmental scan focus on these advo-
cacy types. While a concerted effort must be made to
train advocates in all areas of advocacy, special attention
needs to be paid to the neglected areas of Political and
Fundraising Advocacy.
The information provided by participants offer clear
guidelines to establishing and sustaining an advocacy
program in Africa, despite the challenges faced by advo-
cates. Whilst this paper only highlights a subset of advo-
cacy initiatives on the Continent, there is an opportunity
for a more inclusive dialogue for advocates to share
ideas with each other, connect with other advocates,
learn about other innovative advocacy programs, and
join the global war against cancer. To this end, the
biennial International Workshop on Cancer Advocacy
for African Countries (CAAC) during the next AOR-
TIC International Cancer conference, offers an oppor-
tunity to further Africa’s cancer advocacy initiatives.
The 2013 workshop will include an Advocacy Expo &
Posters session, offering participants the chance to
share, connect, network, discover and learn from each
other. Interested participants can join fellow cancer
advocates, survivors, scientists, clinicians, and policy
makers during the AORTIC 2013 International Cancer
Conference entitled “Cancer in Africa: Bridging Science
& Humanity” in Durban, South Africa (http://www.aor-
tic2013.org).
Additional material
Additional file 1: Data collection instrument is attached as
Appendix I.
List of abbreviations used
AORTIC: African Organisation for Research and Training in Cancer; CAAC:
Cancer Advocacy for African Countries; NGOs: Non-Governmental
Odedina et al. Infectious Agents and Cancer 2013, 8(Suppl 1):S6
http://www.infectagentscancer.com/content/8/S1/S6
Page 5 of 6
Organizations; WHO: World Health Organization; WHO FCTC: WHO
Framework Convention on Tobacco Control.
Authors’ contributions
FTO developed the project, developed the items for the data collection
instrument, conducted the analyses and wrote the manuscript. BR
coordinated the data collection and contributed to the manuscript. PR
assisted with the development of the initial draft of data collection form,
designed the data collection form and collected data and conducted the
data entry.
Competing interests
The authors declare they have no competing interests.
Acknowledgements
Funding for this conference was made possible, in part, by an award
provided by the National Cancer Institute (Award Number R13CA162899).
Additional sponsors were University of Florida’s (UF) College of Pharmacy,
UF Shands Cancer Center, the UF Office of the Vice President of Research,
and The Prostate Net®. We would also like to thank the reviewers of this
article for their constructive feedback.
Declarations
The authors declare that funding for publication of the article was funded
by an award provided by the National Cancer Institute (Award Number
R13CA162899).
This article has been published as part of Infectious Agents and Cancer
Volume 8 Supplement 1, 2013: Selected articles from The International
Workshop on Cancer Advocacy for African Countries (CAAC) 2011. The full
contents of the supplement are available online at http://www.
infectagentscancer.com/supplements/8/S1 The Supplement Editors declare
they have no competing interests.
Author details
1Pharmaceutical Outcomes and Policy, College of Pharmacy, University of
Florida, Gainesville, FL, USA. 2African Organisation for Research and Training
in Cancer (AORTIC), Cape Town, South Africa. 3University of Chicago Medical
Center, Chicago, IL, USA.
Published: 15 July 2013
Reference
1. World Health Organization: Cancer control: Knowledge into action : WHO
guide for effective programmes; module 6. World Health Organization
Geneva, Switzerland;ISBN 92 4 154752 9 2008.
doi:10.1186/1750-9378-8-S1-S6
Cite this article as: Odedina et al.: Setting the stage for Cancer
Advocacy in Africa: how? Infectious Agents and Cancer 2013 8(Suppl 1):S6.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Odedina et al. Infectious Agents and Cancer 2013, 8(Suppl 1):S6
http://www.infectagentscancer.com/content/8/S1/S6
Page 6 of 6
